Anti-GPC3-IRDye800CW
- Generic Name
- Anti-GPC3-IRDye800CW
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Chinese Academy of Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT05047510
- Locations
- 🇨🇳
Zhuhai People's Hospital, Zhuhai, Guangdong, China
🇨🇳The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath